Company news
Theravance Biopharma, Inc. news in 2026
Theravance Biopharma, Inc.'s news releases, calls and decks from 2026, newest first.
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 10, 2026
Theravance Biopharma enters into definitive agreement to be acquired by Zymeworks for $17.00 per share in cash plus a contingent value right
June 29, 2026
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7, 2026
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 18, 2026
Theravance Biopharma Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions
March 3, 2026
Decks in 2026
- Technical Presentation (August 2026)
Technical · 14 slides · Aug 25, 2026
- Investor Presentation (January 2026)
Investor deck · 62 slides · Jan 12, 2026